- Axitinib in the treatment of metastatic renal cell carcinoma2018 | First Faculty of Medicine
- Combination avelumab-axitinib in metastatic renal cell carcinoma treatment2020 | First Faculty of Medicine
- Avelumab plus axitinib combination in treating metastatic renal cell carcinoma2022 | First Faculty of Medicine
- Combination of axitinib and avelumab in the treatment of metastatic renal cell carcinoma2022 | First Faculty of Medicine
- The authors' own experience with axitinib in treating metastatic renal cell carcinoma2018 | First Faculty of Medicine
- Combination therapy of avelumab and axitinib in a patient with renal cell carcinoma in a good prognostic group - case report2022 | Faculty of Medicine in Hradec Králové
- Axitinib in therapy of renal cell cancer2012 | First Faculty of Medicine
- Axtinib in treatment metastatic renal cell carcinoma2016 | First Faculty of Medicine
- Axitinib v léčbě metastatického renálního karcinomu2016 | First Faculty of Medicine
- Účinnost axitinibu u nemocného v léčbě druhé linie metastazujícího karcinomu ledviny2018 | First Faculty of Medicine
- Hemodiafiltration and plasma levels of axitinib in a patient with metastatic renal clear cell carcinoma2018 | Faculty of Medicine in Hradec Králové
- Kazuistika s dlouhodobou léčebnou odpovědí na terapii axitinibem2019 | First Faculty of Medicine
- Renal cell carcinoma 20152015 | First Faculty of Medicine
- Srovnání účinnosti axitinibu a everolimu u pacientů s metastatickým karcinomem ledviny2016 | First Faculty of Medicine
- Komentář ke studii (Axitinib v léčbě pokročilého renálního karcinomu: přehled účinnosti a bezpečnosti)2016 | First Faculty of Medicine
- How to proceed in the treatment of metastatic renal cell carcinoma?2015 | First Faculty of Medicine
- Systemic treatment of renal cell carcinoma and news in 20142014 | First Faculty of Medicine
- Systemic therapy for advanced clear cell renal cell carcinoma in 20132014 | Publication without faculty affiliation
- Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma2012 | First Faculty of Medicine
- Therapy possibilities for elderly patients with metastatic renal cell carcinoma2016 | First Faculty of Medicine
- Tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma2020 | First Faculty of Medicine
- Targeted therapy of metastatic renal cell carcinoma and treatment sequences: a current view +12014 | First Faculty of Medicine
- Immunotherapy of Renal Cell Carcinoma2017 | First Faculty of Medicine
- Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma2019 | Faculty of Medicine in Pilsen
- The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care2021 | Faculty of Medicine in Pilsen
- Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma2021 | Faculty of Medicine in Pilsen
- Komentář ke studii2022 | First Faculty of Medicine